We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
(+21%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
9.89%
Top 10 Holdings %
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$34M |
| 2 |
ExxonMobil
XOM
|
+$33.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$32.7M |
| 4 |
3M
MMM
|
+$32.4M |
| 5 |
McDonald's
MCD
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70M |
| 2 |
W.R. Berkley
WRB
|
+$12.8M |
| 3 |
ISCA
International Speedway Corp
ISCA
|
+$11.2M |
| 4 |
CTWS
Connecticut Water Service Inc
CTWS
|
+$11.2M |
| 5 |
Gen Digital
GEN
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Financials | 12.4% |
| 3 | Industrials | 11.69% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Staples | 11.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Thermo Fisher Scientific
TMO
$196B
| $23.4M | 0.11% |
71,976
+14,545
| +25% | +$4.41M |
|
152
Prologis
PLD
$138B
| $23.3M | 0.11% |
261,347
+14,541
| +6% | +$1.29M |
|
153
Baidu
BIDU
$37.4B
| $23.1M | 0.11% |
182,810
+17,478
| +11% | +$1.99M |
|
154
JD.com
JD
$41.3B
| $22.9M | 0.11% |
650,348
+63,305
| +11% | +$2.04M |
|
155
US Bancorp
USB
$98.4B
| $22.8M | 0.11% |
384,098
+41,317
| +12% | +$2.39M |
|
156
Crown Castle
CCI
$34.1B
| $21.7M | 0.1% |
152,904
+17,832
| +13% | +$2.43M |
|
157
Incyte
INCY
$23.1B
| $21.7M | 0.1% |
248,530
+6,380
| +3% | +$545K |
|
158
Idexx Laboratories
IDXX
$44.5B
| $21.6M | 0.1% |
82,884
+10,363
| +14% | +$2.73M |
|
159
Philip Morris
PM
$300B
| $21.6M | 0.1% |
254,332
+51,713
| +26% | +$4.26M |
|
160
NextEra Energy
NEE
$184B
| $21.6M | 0.1% |
356,080
+69,296
| +24% | +$4.05M |
|
161
CVS Health
CVS
$137B
| $21.5M | 0.1% |
288,756
+64,261
| +29% | +$4.51M |
|
162
PNC Financial Services
PNC
$99.8B
| $21.4M | 0.1% |
134,292
+11,497
| +9% | +$1.73M |
|
163
VeriSign
VRSN
$25.3B
| $21.3M | 0.1% |
110,724
+11,160
| +11% | +$2.1M |
|
164
CME Group
CME
$88.6B
| $21.2M | 0.1% |
105,674
+15,510
| +17% | +$3.18M |
|
165
SiriusXM
SIRI
$10.3B
| $21M | 0.1% |
293,116
+31,339
| +12% | +$2.11M |
|
166
Align Technology
ALGN
$12.5B
| $20.8M | 0.1% |
74,663
+3,427
| +5% | +$855K |
|
167
Synopsys
SNPS
$72.5B
| $20.6M | 0.1% |
148,001
+15,336
| +12% | +$2.1M |
|
168
United Airlines
UAL
$38.1B
| $20.5M | 0.1% |
232,840
+25,496
| +12% | +$2.29M |
|
169
Truist Financial
TFC
$62.3B
| $20.4M | 0.09% |
362,379
+179,237
| +98% | +$9.71M |
|
170
Honeywell
HON
$71.7B
| $20.4M | 0.09% |
122,072
+21,864
| +22% | +$3.57M |
|
171
Union Pacific
UNP
$176B
| $20.1M | 0.09% |
111,370
+17,565
| +19% | +$3.01M |
|
172
Eli Lilly
LLY
$1.02T
| $20.1M | 0.09% |
152,833
+29,567
| +24% | +$3.43M |
|
173
Verisk Analytics
VRSK
$26.4B
| $20M | 0.09% |
133,958
+18,309
| +16% | +$2.71M |
|
174
Mercado Libre
MELI
$92.9B
| $20M | 0.09% |
34,964
+3,560
| +11% | +$1.97M |
|
175
Morgan Stanley
MS
$332B
| $19.9M | 0.09% |
388,636
+50,367
| +15% | +$2.38M |
|
Similar funds
ProShare Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.
- ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
- ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
- ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
- ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
- ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
- ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
- ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.
Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.